Download PDF
J Knee Surg 2015; 28(02): 157-164
DOI: 10.1055/s-0034-1373738
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Joint Salvage Using Sandwich Technique for Giant Cell Tumors around Knee

Zile Singh Kundu
1   Department of Orthopaedics, Pt BD Sharma Post Graduate Institute of Medical sciences, Rohtak, Haryana, India
,
Paritosh Gogna
1   Department of Orthopaedics, Pt BD Sharma Post Graduate Institute of Medical sciences, Rohtak, Haryana, India
,
Rohit Singla
1   Department of Orthopaedics, Pt BD Sharma Post Graduate Institute of Medical sciences, Rohtak, Haryana, India
,
Sukhbir Singh Sangwan
1   Department of Orthopaedics, Pt BD Sharma Post Graduate Institute of Medical sciences, Rohtak, Haryana, India
,
Pradeep Kamboj
1   Department of Orthopaedics, Pt BD Sharma Post Graduate Institute of Medical sciences, Rohtak, Haryana, India
,
Shobit Goyal
1   Department of Orthopaedics, Pt BD Sharma Post Graduate Institute of Medical sciences, Rohtak, Haryana, India
› Author Affiliations
Further Information

Publication History

02 October 2013

11 February 2014

Publication Date:
21 April 2014 (online)

    Permissions and Reprints

Abstract

The most common site for giant cell tumors (GCT) is knee, where the tumor characteristically extends right up to the subarticular bone plate. Extensive curettage with preservation of the joint should be done wherever possible. The alternatives for filling the void left after curettage are either bone graft or bone cement. Sandwich technique uses the advantages of both, taking care to prevent damage to articular cartilage. This study was done to evaluate the results of sandwich technique in tumors around the knee joint. It was a prospective study of 26 consecutive patients (15 females and 11 males) with Campanacci grade II and grade III GCT around the knee, which qualified the inclusion criterion and underwent knee reconstruction with sandwich technique, after extended curettage of the tumor. The mean age of the patients at the time of surgery was 32.73 ± 11.30 years (range, 18–62 years), and the mean follow-up was 3.87 ± 1.26 years (range, 6.5–2 years). At final follow-up, the functional evaluation was done using Musculoskeletal Tumor Society (MSTS) score and measuring range of motion around the knee. Three patients had recurrence of tumor; in one case, we were able to salvage the joint and repeat sandwich surgery was performed, and in the other two cases, the joint was breached; therefore, we resorted to resection arthrodesis. At final follow-up, the mean functional arc of motion around the knee and the mean MSTS score in patients without arthrodesis was 123.52 ± 10.21 degrees (range, 100–130 degrees) and 27.04/30, respectively; all patients were able to do their activities of daily living with ease. Sandwich technique is a good reconstruction procedure in GCT around knee joint with good survival rate, minimal complications, and good functional outcome.

Keywords

giant cell tumors - sandwich technique - knee
 

  • References

  • 1 Turcotte RE, Wunder JS, Isler MH , et al; Canadian Sarcoma Group. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res 2002; (397) 248-258
    PubMedGoogle Scholar
  • 2 Wang HC, Chien SH, Lin GT. Management of grade III giant cell tumors of bones. J Surg Oncol 2005; 92 (1) 46-51
    CrossrefPubMedGoogle Scholar
  • 3 Lausten GS, Jensen PK, Schiødt T, Lund B. Local recurrences in giant cell tumour of bone. Long-term follow up of 31 cases. Int Orthop 1996; 20 (3) 172-176
    CrossrefPubMedGoogle Scholar
  • 4 Szendröi M. Giant-cell tumour of bone. J Bone Joint Surg Br 2004; 86 (1) 5-12
    PubMedGoogle Scholar
  • 5 Niu X, Zhang Q, Hao L , et al. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am 2012; 94 (5) 461-467
    PubMedGoogle Scholar
  • 6 Goodman HJ, Benevenia J. Adjuvant treatment of non-malignant active and aggressive bone tumors. Curr Orthop Pract 2009; 20 (6) 610-615
    CrossrefPubMedGoogle Scholar
  • 7 Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS. Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am 1999; 81 (6) 811-820
    CrossrefPubMedGoogle Scholar
  • 8 Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am 2006; 37 (1) 35-51
    CrossrefPubMedGoogle Scholar
  • 9 Becker WT, Dohle J, Bernd L , et al; Arbeitsgemeinschaft Knochentumoren. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am 2008; 90 (5) 1060-1067
    CrossrefPubMedGoogle Scholar
  • 10 Capanna R, Fabbri N, Bettelli G. Curettage of giant cell tumor of bone. The effect of surgical technique and adjuvants on local recurrence rate. Chir Organi Mov 1990; 75 (1, Suppl): 206
    PubMedGoogle Scholar
  • 11 Vult von Steyern F, Bauer HC, Trovik C , et al; Scandinavian Sarcoma Group. Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study. J Bone Joint Surg Br 2006; 88 (4) 531-535
    PubMedGoogle Scholar
  • 12 Tejwani SG, Hame SL, Eckardt JJ. Subchondral giant-cell tumor of the proximal tibia: arthroscopic treatment for accelerated articular cartilage and meniscal degeneration in two patients. Arthroscopy 2004; 20 (6) 644-649
    CrossrefPubMedGoogle Scholar
  • 13 Puri A, Agarwal M. Treatment of giant cell tumor of bone: Current concepts. Indian J Orthop 2007; 41 (2) 101-108
    CrossrefPubMedGoogle Scholar
  • 14 Kivioja AH, Blomqvist C, Hietaniemi K , et al. Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop 2008; 79 (1) 86-93
    CrossrefPubMedGoogle Scholar
  • 15 Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am 1987; 69 (1) 106-114
    CrossrefPubMedGoogle Scholar
  • 16 Remedios D, Saifuddin A, Pringle J. Radiological and clinical recurrence of giant-cell tumour of bone after the use of cement. J Bone Joint Surg Br 1997; 79 (1) 26-30
    CrossrefPubMedGoogle Scholar
  • 17 Pettersson H, Rydholm A, Persson B. Early radiologic detection of local recurrence after curettage and acrylic cementation of giant cell tumours. Eur J Radiol 1986; 6 (1) 1-4
    PubMedGoogle Scholar
  • 18 Heck Jr RK. Benign/aggressive tumours of bone. In: Canale ST, Beaty JH, , eds. Campbell's Operative Orthopaedics. 11th ed. Philadelphia: Elsevier; 2008: 883-900
    CrossrefGoogle Scholar
  • 19 Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 1993; (286) 241-246
    PubMedGoogle Scholar
  • 20 Kapoor SK, Tiwari A. Resection arthrodesis for giant cell tumors around the knee. Indian J Orthop 2007; 41 (2) 124-128
    CrossrefPubMedGoogle Scholar
  • 21 Muscolo DL, Ayerza MA, Aponte-Tinao LA, Ranalletta M. Use of distal femoral osteoarticular allografts in limb salvage surgery. J Bone Joint Surg Am 2005; 87 (11) 2449-2455
    CrossrefPubMedGoogle Scholar
  • 22 Mankin HJ, Hornicek FJ. Treatment of giant cell tumors with allograft transplants: a 30-year study. Clin Orthop Relat Res 2005; 439 (439) 144-150
    CrossrefPubMedGoogle Scholar
  • 23 Algawahmed H, Turcotte R, Farrokhyar F, Ghert M. High-speed burring with and without the use of surgical adjuvants in the intralesional management of giant cell tumor of bone: a systematic review and meta-analysis. Sarcoma 2010; 2010: pii: 586090
    PubMedGoogle Scholar
  • 24 Leeson MC, Lippitt SB. Thermal aspects of the use of polymethylmethacrylate in large metaphyseal defects in bone. A clinical review and laboratory study. Clin Orthop Relat Res 1993; (295) 239-245
    PubMedGoogle Scholar
  • 25 Prosser GH, Baloch KG, Tillman RM, Carter SR, Grimer RJ. Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone?. Clin Orthop Relat Res 2005; (435) 211-218
    PubMedGoogle Scholar
  • 26 Hirn M, de Silva U, Sidharthan S , et al. Bone defects following curettage do not necessarily need augmentation. Acta Orthop 2009; 80 (1) 4-8
    CrossrefPubMedGoogle Scholar
  • 27 Saha S, Pal S. Improvement of mechanical properties of acrylic bone cement by fiber reinforcement. J Biomech 1984; 17 (7) 467-478
    CrossrefPubMedGoogle Scholar
  • 28 Mjöberg B, Pettersson H, Rosenqvist R, Rydholm A. Bone cement, thermal injury and the radiolucent zone. Acta Orthop Scand 1984; 55 (6) 597-600
    CrossrefPubMedGoogle Scholar
  • 29 Nelson DA, Barker ME, Hamlin BH. Thermal effects of acrylic cementation at bone tumour sites. Int J Hyperthermia 1997; 13 (3) 287-306
    CrossrefPubMedGoogle Scholar
  • 30 von Steyern FV, Kristiansson I, Jonsson K, Mannfolk P, Heinegård D, Rydholm A. Giant-cell tumour of the knee: the condition of the cartilage after treatment by curettage and cementing. J Bone Joint Surg Br 2007; 89 (3) 361-365
    PubMedGoogle Scholar
  • 31 van der Heijden L, van de Sande MA, Heineken AC, Fiocco M, Nelissen RG, Dijkstra PD. Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis?. J Bone Joint Surg Am 2013; 95 (21) e159
    PubMedGoogle Scholar
  • 32 Persson BM, Ekelund L, Lövdahl R, Gunterberg B. Favourable results of acrylic cementation for giant cell tumors. Acta Orthop Scand 1984; 55 (2) 209-214
    CrossrefPubMedGoogle Scholar
  • 33 Ayerza MA, Aponte-Tinao LA, Farfalli GL, Restrepo CA, Muscolo DL. Joint preservation after extensive curettage of knee giant cell tumors. Clin Orthop Relat Res 2009; 467 (11) 2845-2851
    CrossrefPubMedGoogle Scholar
  • 34 Gaston CL, Bhumbra R, Watanuki M , et al. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?. J Bone Joint Surg Br 2011; 93 (12) 1665-1669
    PubMedGoogle Scholar
  • 35 Arkill KP, Winlove CP. Solute transport in the deep and calcified zones of articular cartilage. Osteoarthritis Cartilage 2008; 16 (6) 708-714
    CrossrefPubMedGoogle Scholar
  • 36 Malinin T, Ouellette EA. Articular cartilage nutrition is mediated by subchondral bone: a long-term autograft study in baboons. Osteoarthritis Cartilage 2000; 8 (6) 483-491
    CrossrefPubMedGoogle Scholar
  • 37 Bucholz RW. Nonallograft osteoconductive bone graft substitutes. Clin Orthop Relat Res 2002; (395) 44-52
    PubMedGoogle Scholar
  • 38 Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 2000; 200 (371) 10-27
    PubMedGoogle Scholar
  • 39 Abdelrahman M, Bassiony AA, Shalaby H, Assal MK. Cryosurgery and impaction subchondral bone graft for the treatment of giant cell tumor around the knee. HSS J 2009; 5 (2) 123-128
    CrossrefPubMedGoogle Scholar
  • 40 Banerjee S, Sabui KK, Chatterjee R, Das AK, Mondal J, Pal DK. Sandwich reconstruction technique for subchondral giant cell tumors around the knee. Curr Orthop Pract 2012; 23 (5) 459-466
    CrossrefPubMedGoogle Scholar
  • 41 Zhen W, Yaotian H, Songjian L, Ge L, Qingliang W. Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft. J Bone Joint Surg Br 2004; 86 (2) 212-216
    CrossrefPubMedGoogle Scholar
  • 42 Ghert MA, Rizzo M, Harrelson JM, Scully SP. Giant-cell tumor of the appendicular skeleton. Clin Orthop Relat Res 2002; (400) 201-210
    PubMedGoogle Scholar
  • 43 O'Donnell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ. Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am 1994; 76 (12) 1827-1833
    PubMedGoogle Scholar